HOMEOPATHY FOR GOUT AND/OR HYPERURICEMIA: PROTOCOL FOR A SYSTEMATIC REVIEW
Abstract
Background: Gout, is a painful type of arthritis that occurs due to an increase in serum uric acid levels i.e. Hyperuricemia. Hyperuricemia is a worldwide health problem that is often dealt with Homeopathy. The objective of this review will be to assess the role of homeopathic medicines in the management of Hyperuricemia and primary Gout. Methods/Design: To conduct syatematic review, authors will 3.6search Medline, EMBASE, CENTRAL, AMED, CAM-Quest, CORE-Hom, ChiroACCESS (MANTIS interface), LILACS (Biblioteca virtual emsalud interface), Google Scholar studies from January 2001 up to January 2022. The review will include all types of Randomised Controlled Trials (RCTs), Observational studies, well-presented case reports published in peer-reviewed journals, in vitro studies and animal experimentation. Studies with participants of all ages, and both sexes will be included. Cases with either acute gouty attack, those in inter critical period, or chronic gout will also be included. Studies related exclusively to allopathic and other CAMs (Ayurveda, Unani, Siddha, Yoga, and Naturopathy) will be excluded from this review. The methodology will include Jadad scoring for clinical trials, the internal validity of RCTs by the Cochrane collaboration tool, and the internal validity of observational studies and case reports by the Joanna Briggs Institute (JBI) criteria and JBI appraisal checklist, respectively.
Keywords: Gout, Hyperuricemia, Observational studies, Homoeopathy, Randomized control trial
References
Choi HK, Mount DB, Reginato AM. Pathogenesis of Gout. Ann Intern Med. 2005;143:499–516.
Barr WG. Uric Acid. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 165. Available from: https://www.ncbi.nlm.nih.gov/books/NBK273/
Kuo C.F., Grainge M.J., Zhang W., Doherty M. Global epidemiology of Gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649–662. [PubMed] [Google Scholar]
Raja S, Kumar A, Aahooja RD, Thakuria U, Ochani S, Shaukat F. Frequency of Hyperuricemia and its Risk Factors in the Adult Population. Cureus. 2019;11(3):e4198. Published 2019 Mar 6. doi:10.7759/cureus.4198
Neogi T. Clinical practice.Gout. N Engl J Med. 2011;364:443–52. [PubMed] [Google Scholar]
Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-2416
Terkeltaub RA. Gout. N Engl J Med 2003;349:1647-1655
Fam AG. Gout in the elderly: clinical presentation and treatment. Drugs Aging 1998;13:229-243
Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia. Am Fam Physician 1999;59:925-934
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing the risk of bias in randomized trials. BMJ. 2011 Oct; 343:d5928.
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P. Joanna Briggs institute reviewer’s manual. The Joanna Briggs Institute. 2017;5.
